BPI Labs
BPI Labs (Largo, FL) — associated with Belcher Pharmaceuticals · Largo, FL
We do not sell medication and we have no commercial relationship with BPI Labs. Everything below is either published by a regulator or published by the pharmacy about itself, labelled as such and dated. We give you the official lookups rather than asking you to take our word for the current position.
The short answer
- BPI Labs is the trading name of BPI Labs (Largo, FL) — associated with Belcher Pharmaceuticals, based in Largo, FL. Regulators file under the legal name, so search that.
- Registration: 503B. A 503B outsourcing facility that is also an FDA-registered drug manufacturer, an unusual combination it has described as making it the only FDA-registered manufacturer also running a 503B pharmacy producing GLP-1s. As a 503B it is subject to FDA cGMP requirements and routine FDA inspection.
- No FDA warning letter naming BPI Labs (Largo, FL) — associated with Belcher Pharmaceuticals surfaced in our check on July 29, 2026 — but there is 1 other public record below, dated 2024. A clean FDA record is not the same as a clean record.
- Compounded semaglutide and tirzepatide are NOT FDA-approved as finished products, whichever pharmacy prepares them. FDA does not review them for safety, effectiveness or manufacturing quality.
Registration and licence
A 503B outsourcing facility that is also an FDA-registered drug manufacturer, an unusual combination it has described as making it the only FDA-registered manufacturer also running a 503B pharmacy producing GLP-1s. As a 503B it is subject to FDA cGMP requirements and routine FDA inspection.
Regulatory record
Every item below is a public document, linked to its source, with the date it was issued and the dates of any inspection behind it. Where the agency recorded the company's response, a completed recall, or which legal entity a record actually concerns, that is included — leaving it out would misrepresent the record. Where the company has answered publicly, its answer is printed too.
- FDA Form 483 (observations)FDA inspection of Belcher Pharmaceuticals
Reported FDA inspection findings at Belcher Pharmaceuticals included failure to conduct testing for impurities before releasing packages of injectable testosterone.
Which entity this concerns: These findings concern Belcher Pharmaceuticals, the associated manufacturer, and not BPI Labs’ 503B outsourcing operation as a separate registrant. We have recorded the year rather than a precise date because we could not confirm one from a primary document. Treat the date as approximate and check the FDA inspection record before relying on it.
Our check on July 29, 2026 did not surface a published close-out. That means we did not find one, not that none exists.
Read it on fda.gov
What it compounds for GLP-1 patients
- · Compounded semaglutide (discontinued April 2026)
- · Compounded tirzepatide (discontinued April 2026)
Compounded semaglutide and tirzepatide are not FDA-approved as finished drug products. FDA does not review them for safety, effectiveness or manufacturing quality before they reach patients. That applies to every compounded GLP-1 regardless of which pharmacy prepares it, and it is a separate question from whether the pharmacy is licensed.
If you would rather not take that trade, the FDA-approved oral products now start at $149/month direct from their manufacturers — see the cheapest routes compared.
Check it yourself
Search under the legal name — BPI Labs (Largo, FL) — associated with Belcher Pharmaceuticals — not the brand. Regulators file under the legal entity, and searching the trading name alone is how records get missed.
- FDA — Registered Outsourcing Facilities (503B)
The authoritative list of pharmacies registered with the FDA as 503B outsourcing facilities (the higher-oversight compounding tier). If a pharmacy claims to be 503B, it should appear here.
- FDA — 503A vs 503B explainer
What the two compounding categories mean: 503A = patient-specific prescriptions under state board oversight; 503B = larger-batch outsourcing facilities under direct FDA cGMP inspection.
- FDA — Warning Letters search
Search the FDA’s public warning-letter database by company name to see whether a pharmacy has an open compliance action. Confirm the date and status — letters can be resolved.
- NABP — Verify a pharmacy / .pharmacy
The National Association of Boards of Pharmacy tools flag rogue online pharmacies and list accredited ones. Legitimate US pharmacies are licensed by a state board.
- LegitScript — Certification lookup
LegitScript certifies healthcare merchants that meet legal + safety standards. Many reputable telehealth GLP-1 providers display a LegitScript badge you can verify here.
- Your state Board of Pharmacy
Every US pharmacy must be licensed by the state board where it operates (and often where it ships). State boards publish license status + disciplinary history.
Questions people ask about BPI Labs
Is BPI Labs a licensed pharmacy?
We have not been able to verify a published state licence record for BPI Labs. Use your state board of pharmacy's lookup to check before buying.
What is the regulatory record for BPI Labs?
Our check on July 29, 2026 found no FDA warning letter naming BPI Labs (Largo, FL) — associated with Belcher Pharmaceuticals. That does not mean the record is empty: 1 other public document appears above, dated 2024, including state board of pharmacy proceedings. Read them with the company's responses, which are printed alongside.
Is a Form 483 the same as a warning letter?
No, and the difference matters. A Form 483 is the list of observations an FDA investigator leaves at the end of an inspection. It records what the investigator saw, not an agency finding that the law was broken. A warning letter comes later and states FDA's position that violations occurred. Firms respond to 483s and many are resolved without a warning letter ever being issued.
Does BPI Labs make FDA-approved GLP-1 medication?
No compounding pharmacy does. BPI Labs publicly compounds compounded semaglutide (discontinued april 2026) and compounded tirzepatide (discontinued april 2026). Compounded drugs are not FDA-approved: the agency does not review them for safety, effectiveness or manufacturing quality before they reach patients. That is true of every compounded product regardless of which pharmacy prepares it, and it is a different thing from the pharmacy being licensed or unlicensed.
How do I check BPI Labs myself?
Three free lookups settle it: the FDA warning-letter database, searched by the legal name (BPI Labs (Largo, FL) — associated with Belcher Pharmaceuticals) rather than the trading name; the FDA list of registered 503B outsourcing facilities, if the pharmacy claims 503B status; and your state board of pharmacy's licence verification. All three are linked at the bottom of this page. Check the legal name — regulators file under it, and searching the brand alone misses records.